David T Selewski1, Dylan M Hyatt2, Kevin M Bennett3, Jennifer R Charlton4. 1. Department of Pediatrics & Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan. 2. University of Virginia, School of Medicine, Charlottesville, Virginia. 3. Department of Biology, University of Hawaii at Manoa, Honolulu, Hawaii. 4. Division of Nephrology, Department of Pediatrics, University of Virginia, Charlottesville, Virginia, USA.
Abstract
PURPOSE OF REVIEW: Despite abundant evidence in adults, the relationship between acute kidney injury (AKI) and chronic kidney disease (CKD) remains unanswered in pediatrics. Obstacles to overcome include the challenges defining these entities and the lack of long-term follow-up studies. This review focuses on pediatric populations at high-risk for AKI, the evidence of the long-term effect of AKI on renal health, and biomarkers to detect renal disease. RECENT FINDINGS: AKI in critically ill children and neonates is common and independently associated with adverse outcomes. Patients with diabetes and sickle cell disease along with neonates with necrotizing enterocolitis have been identified as high-risk for AKI. Preterm birth and neonates with AKI have signs of renal dysfunction early in childhood. Urinary biomarkers may identify AKI and CKD earlier than traditional biomarkers, but more work is necessary to determine their clinical utility. Promising technological advances including the ability to determine nephron number noninvasively will expand our ability to characterize the AKI to CKD transition. SUMMARY: AKI is common and associated with poor outcomes. It is probable that AKI is a harbinger to CKD in pediatric populations. However, we currently lack the tools to definitely answer this question and more research is needed.
PURPOSE OF REVIEW: Despite abundant evidence in adults, the relationship between acute kidney injury (AKI) and chronic kidney disease (CKD) remains unanswered in pediatrics. Obstacles to overcome include the challenges defining these entities and the lack of long-term follow-up studies. This review focuses on pediatric populations at high-risk for AKI, the evidence of the long-term effect of AKI on renal health, and biomarkers to detect renal disease. RECENT FINDINGS: AKI in critically ill children and neonates is common and independently associated with adverse outcomes. Patients with diabetes and sickle cell disease along with neonates with necrotizing enterocolitis have been identified as high-risk for AKI. Preterm birth and neonates with AKI have signs of renal dysfunction early in childhood. Urinary biomarkers may identify AKI and CKD earlier than traditional biomarkers, but more work is necessary to determine their clinical utility. Promising technological advances including the ability to determine nephron number noninvasively will expand our ability to characterize the AKI to CKD transition. SUMMARY: AKI is common and associated with poor outcomes. It is probable that AKI is a harbinger to CKD in pediatric populations. However, we currently lack the tools to definitely answer this question and more research is needed.
Authors: Cory N Criss; David T Selewski; Bipin Sunkara; Joshua S Gish; Lily Hsieh; Jennifer S Mcleod; Jason O Robertson; Niki Matusko; Samir K Gadepalli Journal: Pediatr Nephrol Date: 2017-10-05 Impact factor: 3.714
Authors: Joshua J Blinder; Lisa A Asaro; David Wypij; David T Selewski; Michael S D Agus; Michael Gaies; Michael A Ferguson Journal: Pediatr Crit Care Med Date: 2017-07 Impact factor: 3.624
Authors: Omar Alkandari; K Allen Eddington; Ayaz Hyder; France Gauvin; Thierry Ducruet; Ronald Gottesman; Véronique Phan; Michael Zappitelli Journal: Crit Care Date: 2011-06-10 Impact factor: 9.097
Authors: Aurélie De Mul; Paloma Parvex; Alice Héneau; Valérie Biran; Antoine Poncet; Olivier Baud; Marie Saint-Faust; Alexandra Wilhelm-Bals Journal: Clin J Am Soc Nephrol Date: 2022-06-28 Impact factor: 10.614